The Congenital Diaphragmatic Hernia Drug is a drug for the treatment of congenital diseases that cause a series of symptoms due to the congenital defect in the development of the diaphragmatic muscle, which causes the abdominal organs to herniate into the thoracic cavity.
This report contains market size and forecasts of Congenital Diaphragmatic Hernia Drug in global, including the following market information:
Global Congenital Diaphragmatic Hernia Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Congenital Diaphragmatic Hernia Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Congenital Diaphragmatic Hernia Drug companies in 2021 (%)
The global Congenital Diaphragmatic Hernia Drug market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Posterolateral Bochdalek Hernia Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Congenital Diaphragmatic Hernia Drug include B. Braun Melsungen AG, Cousin Biotech, ASPIDE MEDICAL, Bard, WL Gore, Cook Medical, Maquet, DIPROMED and Integra LifeSciences Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Congenital Diaphragmatic Hernia Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Congenital Diaphragmatic Hernia Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Congenital Diaphragmatic Hernia Drug Market Segment Percentages, by Type, 2021 (%)
Posterolateral Bochdalek Hernia
Anterior Morgagni Hernia
Hiatal Hernia
Global Congenital Diaphragmatic Hernia Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Congenital Diaphragmatic Hernia Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Congenital Diaphragmatic Hernia Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Congenital Diaphragmatic Hernia Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Congenital Diaphragmatic Hernia Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Congenital Diaphragmatic Hernia Drug revenues share in global market, 2021 (%)
Key companies Congenital Diaphragmatic Hernia Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Congenital Diaphragmatic Hernia Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
B. Braun Melsungen AG
Cousin Biotech
ASPIDE MEDICAL
Bard
WL Gore
Cook Medical
Maquet
DIPROMED
Integra LifeSciences Corporation
Herniamesh
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Congenital Diaphragmatic Hernia Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Congenital Diaphragmatic Hernia Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Congenital Diaphragmatic Hernia Drug Overall Market Size
2.1 Global Congenital Diaphragmatic Hernia Drug Market Size: 2021 VS 2028
2.2 Global Congenital Diaphragmatic Hernia Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Congenital Diaphragmatic Hernia Drug Sales: 2017-2028
3 Company Landscape
3.1 Top Congenital Diaphragmatic Hernia Drug Players in Global Market
3.2 Top Global Congenital Diaphragmatic Hernia Drug Companies Ranked by Revenue
3.3 Global Congenital Diaphragmatic Hernia Drug Revenue by Companies
3.4 Global Congenital Diaphragmatic Hernia Drug Sales by Companies
3.5 Global Congenital Diaphragmatic Hernia Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Congenital Diaphragmatic Hernia Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Congenital Diaphragmatic Hernia Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Congenital Diaphragmatic Hernia Drug Players in Global Market
3.8.1 List of Global Tier 1 Congenital Diaphragmatic Hernia Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Congenital Diaphragmatic Hernia Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Congenital Diaphragmatic Hernia Drug Market Size Markets, 2021 & 2028
4.1.2 Posterolateral Bochdalek Hernia
4.1.3 Anterior Morgagni Hernia
4.1.4 Hiatal Hernia
4.2 By Type - Global Congenital Diaphragmatic Hernia Drug Revenue & Forecasts
4.2.1 By Type - Global Congenital Diaphragmatic Hernia Drug Revenue, 2017-2022
4.2.2 By Type - Global Congenital Diaphragmatic Hernia Drug Revenue, 2023-2028
4.2.3 By Type - Global Congenital Diaphragmatic Hernia Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Congenital Diaphragmatic Hernia Drug Sales & Forecasts
4.3.1 By Type - Global Congenital Diaphragmatic Hernia Drug Sales, 2017-2022
4.3.2 By Type - Global Congenital Diaphragmatic Hernia Drug Sales, 2023-2028
4.3.3 By Type - Global Congenital Diaphragmatic Hernia Drug Sales Market Share, 2017-2028
4.4 By Type - Global Congenital Diaphragmatic Hernia Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Congenital Diaphragmatic Hernia Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Congenital Diaphragmatic Hernia Drug Revenue & Forecasts
5.2.1 By Application - Global Congenital Diaphragmatic Hernia Drug Revenue, 2017-2022
5.2.2 By Application - Global Congenital Diaphragmatic Hernia Drug Revenue, 2023-2028
5.2.3 By Application - Global Congenital Diaphragmatic Hernia Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Congenital Diaphragmatic Hernia Drug Sales & Forecasts
5.3.1 By Application - Global Congenital Diaphragmatic Hernia Drug Sales, 2017-2022
5.3.2 By Application - Global Congenital Diaphragmatic Hernia Drug Sales, 2023-2028
5.3.3 By Application - Global Congenital Diaphragmatic Hernia Drug Sales Market Share, 2017-2028
5.4 By Application - Global Congenital Diaphragmatic Hernia Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Congenital Diaphragmatic Hernia Drug Market Size, 2021 & 2028
6.2 By Region - Global Congenital Diaphragmatic Hernia Drug Revenue & Forecasts
6.2.1 By Region - Global Congenital Diaphragmatic Hernia Drug Revenue, 2017-2022
6.2.2 By Region - Global Congenital Diaphragmatic Hernia Drug Revenue, 2023-2028
6.2.3 By Region - Global Congenital Diaphragmatic Hernia Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Congenital Diaphragmatic Hernia Drug Sales & Forecasts
6.3.1 By Region - Global Congenital Diaphragmatic Hernia Drug Sales, 2017-2022
6.3.2 By Region - Global Congenital Diaphragmatic Hernia Drug Sales, 2023-2028
6.3.3 By Region - Global Congenital Diaphragmatic Hernia Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Congenital Diaphragmatic Hernia Drug Revenue, 2017-2028
6.4.2 By Country - North America Congenital Diaphragmatic Hernia Drug Sales, 2017-2028
6.4.3 US Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.4.4 Canada Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.4.5 Mexico Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Congenital Diaphragmatic Hernia Drug Revenue, 2017-2028
6.5.2 By Country - Europe Congenital Diaphragmatic Hernia Drug Sales, 2017-2028
6.5.3 Germany Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.5.4 France Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.5.5 U.K. Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.5.6 Italy Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.5.7 Russia Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.5.8 Nordic Countries Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.5.9 Benelux Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Congenital Diaphragmatic Hernia Drug Revenue, 2017-2028
6.6.2 By Region - Asia Congenital Diaphragmatic Hernia Drug Sales, 2017-2028
6.6.3 China Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.6.4 Japan Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.6.5 South Korea Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.6.6 Southeast Asia Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.6.7 India Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Congenital Diaphragmatic Hernia Drug Revenue, 2017-2028
6.7.2 By Country - South America Congenital Diaphragmatic Hernia Drug Sales, 2017-2028
6.7.3 Brazil Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.7.4 Argentina Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Congenital Diaphragmatic Hernia Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Congenital Diaphragmatic Hernia Drug Sales, 2017-2028
6.8.3 Turkey Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.8.4 Israel Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
6.8.6 UAE Congenital Diaphragmatic Hernia Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 B. Braun Melsungen AG
7.1.1 B. Braun Melsungen AG Corporate Summary
7.1.2 B. Braun Melsungen AG Business Overview
7.1.3 B. Braun Melsungen AG Congenital Diaphragmatic Hernia Drug Major Product Offerings
7.1.4 B. Braun Melsungen AG Congenital Diaphragmatic Hernia Drug Sales and Revenue in Global (2017-2022)
7.1.5 B. Braun Melsungen AG Key News
7.2 Cousin Biotech
7.2.1 Cousin Biotech Corporate Summary
7.2.2 Cousin Biotech Business Overview
7.2.3 Cousin Biotech Congenital Diaphragmatic Hernia Drug Major Product Offerings
7.2.4 Cousin Biotech Congenital Diaphragmatic Hernia Drug Sales and Revenue in Global (2017-2022)
7.2.5 Cousin Biotech Key News
7.3 ASPIDE MEDICAL
7.3.1 ASPIDE MEDICAL Corporate Summary
7.3.2 ASPIDE MEDICAL Business Overview
7.3.3 ASPIDE MEDICAL Congenital Diaphragmatic Hernia Drug Major Product Offerings
7.3.4 ASPIDE MEDICAL Congenital Diaphragmatic Hernia Drug Sales and Revenue in Global (2017-2022)
7.3.5 ASPIDE MEDICAL Key News
7.4 Bard
7.4.1 Bard Corporate Summary
7.4.2 Bard Business Overview
7.4.3 Bard Congenital Diaphragmatic Hernia Drug Major Product Offerings
7.4.4 Bard Congenital Diaphragmatic Hernia Drug Sales and Revenue in Global (2017-2022)
7.4.5 Bard Key News
7.5 WL Gore
7.5.1 WL Gore Corporate Summary
7.5.2 WL Gore Business Overview
7.5.3 WL Gore Congenital Diaphragmatic Hernia Drug Major Product Offerings
7.5.4 WL Gore Congenital Diaphragmatic Hernia Drug Sales and Revenue in Global (2017-2022)
7.5.5 WL Gore Key News
7.6 Cook Medical
7.6.1 Cook Medical Corporate Summary
7.6.2 Cook Medical Business Overview
7.6.3 Cook Medical Congenital Diaphragmatic Hernia Drug Major Product Offerings
7.6.4 Cook Medical Congenital Diaphragmatic Hernia Drug Sales and Revenue in Global (2017-2022)
7.6.5 Cook Medical Key News
7.7 Maquet
7.7.1 Maquet Corporate Summary
7.7.2 Maquet Business Overview
7.7.3 Maquet Congenital Diaphragmatic Hernia Drug Major Product Offerings
7.7.4 Maquet Congenital Diaphragmatic Hernia Drug Sales and Revenue in Global (2017-2022)
7.7.5 Maquet Key News
7.8 DIPROMED
7.8.1 DIPROMED Corporate Summary
7.8.2 DIPROMED Business Overview
7.8.3 DIPROMED Congenital Diaphragmatic Hernia Drug Major Product Offerings
7.8.4 DIPROMED Congenital Diaphragmatic Hernia Drug Sales and Revenue in Global (2017-2022)
7.8.5 DIPROMED Key News
7.9 Integra LifeSciences Corporation
7.9.1 Integra LifeSciences Corporation Corporate Summary
7.9.2 Integra LifeSciences Corporation Business Overview
7.9.3 Integra LifeSciences Corporation Congenital Diaphragmatic Hernia Drug Major Product Offerings
7.9.4 Integra LifeSciences Corporation Congenital Diaphragmatic Hernia Drug Sales and Revenue in Global (2017-2022)
7.9.5 Integra LifeSciences Corporation Key News
7.10 Herniamesh
7.10.1 Herniamesh Corporate Summary
7.10.2 Herniamesh Business Overview
7.10.3 Herniamesh Congenital Diaphragmatic Hernia Drug Major Product Offerings
7.10.4 Herniamesh Congenital Diaphragmatic Hernia Drug Sales and Revenue in Global (2017-2022)
7.10.5 Herniamesh Key News
8 Global Congenital Diaphragmatic Hernia Drug Production Capacity, Analysis
8.1 Global Congenital Diaphragmatic Hernia Drug Production Capacity, 2017-2028
8.2 Congenital Diaphragmatic Hernia Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Congenital Diaphragmatic Hernia Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Congenital Diaphragmatic Hernia Drug Supply Chain Analysis
10.1 Congenital Diaphragmatic Hernia Drug Industry Value Chain
10.2 Congenital Diaphragmatic Hernia Drug Upstream Market
10.3 Congenital Diaphragmatic Hernia Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Congenital Diaphragmatic Hernia Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Congenital Diaphragmatic Hernia Drug in Global Market
Table 2. Top Congenital Diaphragmatic Hernia Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Congenital Diaphragmatic Hernia Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Congenital Diaphragmatic Hernia Drug Revenue Share by Companies, 2017-2022
Table 5. Global Congenital Diaphragmatic Hernia Drug Sales by Companies, (K Units), 2017-2022
Table 6. Global Congenital Diaphragmatic Hernia Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Congenital Diaphragmatic Hernia Drug Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Congenital Diaphragmatic Hernia Drug Product Type
Table 9. List of Global Tier 1 Congenital Diaphragmatic Hernia Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Congenital Diaphragmatic Hernia Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Congenital Diaphragmatic Hernia Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Congenital Diaphragmatic Hernia Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Congenital Diaphragmatic Hernia Drug Sales (K Units), 2017-2022
Table 15. By Type - Global Congenital Diaphragmatic Hernia Drug Sales (K Units), 2023-2028
Table 16. By Application - Global Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Congenital Diaphragmatic Hernia Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Congenital Diaphragmatic Hernia Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Congenital Diaphragmatic Hernia Drug Sales (K Units), 2017-2022
Table 20. By Application - Global Congenital Diaphragmatic Hernia Drug Sales (K Units), 2023-2028
Table 21. By Region - Global Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Congenital Diaphragmatic Hernia Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Congenital Diaphragmatic Hernia Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Congenital Diaphragmatic Hernia Drug Sales (K Units), 2017-2022
Table 25. By Region - Global Congenital Diaphragmatic Hernia Drug Sales (K Units), 2023-2028
Table 26. By Country - North America Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Congenital Diaphragmatic Hernia Drug Sales, (K Units), 2017-2022
Table 29. By Country - North America Congenital Diaphragmatic Hernia Drug Sales, (K Units), 2023-2028
Table 30. By Country - Europe Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Congenital Diaphragmatic Hernia Drug Sales, (K Units), 2017-2022
Table 33. By Country - Europe Congenital Diaphragmatic Hernia Drug Sales, (K Units), 2023-2028
Table 34. By Region - Asia Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Congenital Diaphragmatic Hernia Drug Sales, (K Units), 2017-2022
Table 37. By Region - Asia Congenital Diaphragmatic Hernia Drug Sales, (K Units), 2023-2028
Table 38. By Country - South America Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Congenital Diaphragmatic Hernia Drug Sales, (K Units), 2017-2022
Table 41. By Country - South America Congenital Diaphragmatic Hernia Drug Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Congenital Diaphragmatic Hernia Drug Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Congenital Diaphragmatic Hernia Drug Sales, (K Units), 2023-2028
Table 46. B. Braun Melsungen AG Corporate Summary
Table 47. B. Braun Melsungen AG Congenital Diaphragmatic Hernia Drug Product Offerings
Table 48. B. Braun Melsungen AG Congenital Diaphragmatic Hernia Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Cousin Biotech Corporate Summary
Table 50. Cousin Biotech Congenital Diaphragmatic Hernia Drug Product Offerings
Table 51. Cousin Biotech Congenital Diaphragmatic Hernia Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. ASPIDE MEDICAL Corporate Summary
Table 53. ASPIDE MEDICAL Congenital Diaphragmatic Hernia Drug Product Offerings
Table 54. ASPIDE MEDICAL Congenital Diaphragmatic Hernia Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Bard Corporate Summary
Table 56. Bard Congenital Diaphragmatic Hernia Drug Product Offerings
Table 57. Bard Congenital Diaphragmatic Hernia Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. WL Gore Corporate Summary
Table 59. WL Gore Congenital Diaphragmatic Hernia Drug Product Offerings
Table 60. WL Gore Congenital Diaphragmatic Hernia Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Cook Medical Corporate Summary
Table 62. Cook Medical Congenital Diaphragmatic Hernia Drug Product Offerings
Table 63. Cook Medical Congenital Diaphragmatic Hernia Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Maquet Corporate Summary
Table 65. Maquet Congenital Diaphragmatic Hernia Drug Product Offerings
Table 66. Maquet Congenital Diaphragmatic Hernia Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. DIPROMED Corporate Summary
Table 68. DIPROMED Congenital Diaphragmatic Hernia Drug Product Offerings
Table 69. DIPROMED Congenital Diaphragmatic Hernia Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Integra LifeSciences Corporation Corporate Summary
Table 71. Integra LifeSciences Corporation Congenital Diaphragmatic Hernia Drug Product Offerings
Table 72. Integra LifeSciences Corporation Congenital Diaphragmatic Hernia Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Herniamesh Corporate Summary
Table 74. Herniamesh Congenital Diaphragmatic Hernia Drug Product Offerings
Table 75. Herniamesh Congenital Diaphragmatic Hernia Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Congenital Diaphragmatic Hernia Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Congenital Diaphragmatic Hernia Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Congenital Diaphragmatic Hernia Drug Production by Region, 2017-2022 (K Units)
Table 79. Global Congenital Diaphragmatic Hernia Drug Production by Region, 2023-2028 (K Units)
Table 80. Congenital Diaphragmatic Hernia Drug Market Opportunities & Trends in Global Market
Table 81. Congenital Diaphragmatic Hernia Drug Market Drivers in Global Market
Table 82. Congenital Diaphragmatic Hernia Drug Market Restraints in Global Market
Table 83. Congenital Diaphragmatic Hernia Drug Raw Materials
Table 84. Congenital Diaphragmatic Hernia Drug Raw Materials Suppliers in Global Market
Table 85. Typical Congenital Diaphragmatic Hernia Drug Downstream
Table 86. Congenital Diaphragmatic Hernia Drug Downstream Clients in Global Market
Table 87. Congenital Diaphragmatic Hernia Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Congenital Diaphragmatic Hernia Drug Segment by Type
Figure 2. Congenital Diaphragmatic Hernia Drug Segment by Application
Figure 3. Global Congenital Diaphragmatic Hernia Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Congenital Diaphragmatic Hernia Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Congenital Diaphragmatic Hernia Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Congenital Diaphragmatic Hernia Drug Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Congenital Diaphragmatic Hernia Drug Revenue in 2021
Figure 9. By Type - Global Congenital Diaphragmatic Hernia Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Congenital Diaphragmatic Hernia Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Congenital Diaphragmatic Hernia Drug Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Congenital Diaphragmatic Hernia Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Congenital Diaphragmatic Hernia Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Congenital Diaphragmatic Hernia Drug Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Congenital Diaphragmatic Hernia Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Congenital Diaphragmatic Hernia Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Congenital Diaphragmatic Hernia Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Congenital Diaphragmatic Hernia Drug Sales Market Share, 2017-2028
Figure 19. US Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Congenital Diaphragmatic Hernia Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Congenital Diaphragmatic Hernia Drug Sales Market Share, 2017-2028
Figure 24. Germany Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Congenital Diaphragmatic Hernia Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Congenital Diaphragmatic Hernia Drug Sales Market Share, 2017-2028
Figure 33. China Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Congenital Diaphragmatic Hernia Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Congenital Diaphragmatic Hernia Drug Sales Market Share, 2017-2028
Figure 40. Brazil Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Congenital Diaphragmatic Hernia Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Congenital Diaphragmatic Hernia Drug Sales Market Share, 2017-2028
Figure 44. Turkey Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Congenital Diaphragmatic Hernia Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Congenital Diaphragmatic Hernia Drug Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Congenital Diaphragmatic Hernia Drug by Region, 2021 VS 2028
Figure 50. Congenital Diaphragmatic Hernia Drug Industry Value Chain
Figure 51. Marketing Channels